Lexi Ventures
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://www.lexi.vc
- HQ
- CA
Lexi Ventures provides seed funding for US-based companies building around DNA, RNA, cells, and omics. The firm describes its focus as backing the engineers writing the code of life.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Seed | Not enough dated deals |
| Sectors | Biotech, Synthetic biology | Not enough dated deals |
| Regions | US | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Lexi Ventures Fund I LP Lexi Ventures backs seed-stage US companies engineering DNA, RNA, cells and 'omics, including gene editing, RNA delivery, diagnostics and bio tools for therapeutics and industrial applications. Inferred from the firm's website | 2025 | $525K to $10M (Form D) | Open, writing first checks |
03 · People across funds
- Jonah Proujansky-Bell, Managing Member of the General Partner of the Issuer
Lexi Ventures Fund I LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026